Pediatrix Medical Group (NYSE:MD – Free Report) had its price target decreased by Truist Financial from $10.50 to $10.00 in a research note issued to investors on Wednesday, Benzinga reports. Truist Financial currently has a hold rating on the stock. Separately, UBS Group began coverage on shares of Pediatrix Medical Group in a research report […]
Pediatrix Medical Group (NYSE:MD – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.09), Briefing.com reports. The company had revenue of $506.60 million during the quarter, compared to analyst estimates of $507.59 million. Pediatrix Medical […]
Shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as $12.59 and last traded at $12.76, with a volume of 439130 shares changing hands. The stock had previously closed at $12.73. Analyst Upgrades and Downgrades Separately, StockNews.com initiated […]
Palisade Capital Management LLC NJ cut its position in Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 742,289 shares of the company’s stock after selling 27,602 shares during the quarter. Palisade Capital Management LLC […]
Pediatrix Medical Group (NYSE:MD – Get Rating) had its target price reduced by Mizuho from $17.00 to $15.00 in a research report report published on Wednesday morning, The Fly reports. MD has been the subject of a number of other reports. Credit Suisse Group reduced their price objective on shares of Pediatrix Medical Group from […]